Lab Tests Reveal Majority of Products Contain Less CBD than Advertised

RALEIGH, N.C., Dec. 3, 2019 /PRNewswire/ -- Remedy Review, the venture capital-backed independent observer for natural health, recently conducted lab tests of CBD products. The results reinforce the need for independent monitoring and testing.

• 8 of 15 products were mislabeled—containing at least 20% less CBD than advertised
• All gummies tested were mislabeled—one contained zero CBD
• 60% of vape liquids contained flammable, toxic solvents or pesticides

Tested products included some sent to the company for review and others purchased from prominent e-commerce platforms. Each of the products was tested for cannabinoid content, terpenes, heavy metals, pesticides, and residual solvents. Cannabinoid tests were used to measure label accuracy.

"Demand for CBD has outpaced quality control standards," said Marc Lewis, Executive Editor of Remedy Review. "Brands that bring poor quality products to market put consumers at risk, waste people's money, and erode trust in a promising new product category."

Lab tests were conducted at Avazyme, Inc., a contract research and testing laboratory based in Durham, North Carolina.

"We at Avazyme, support the entire hemp value chain from Farm to Farmacy, with our accurate and reliable testing solutions and openness in knowledge sharing," said Volker Bornemann, Ph.D., CEO of Avayzme, Inc. "Our goal is to ensure that our customers meet the highest standards of product safety and product quality, thereby fostering trust with their clients and their end-consumers."

As an independent observer, Remedy Review hopes its Seal of Approval will aid consumers in a confusing space by adding an additional layer of scrutiny to a growing online marketplace.

More on Rezul News

• DivX Unveils Major DivX Software Update: Seamless Video Sharing and Customizable Playback Now Available
• Nespolo Mechanical Helps New Mexico Families Save Thousands on Heating Costs This Fall
• Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
• IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture
• Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy

A summary of test results can be found at https://www.remedyreview.com/industry/lab-test-results.

About Remedy Review

Remedy Review is dedicated to advancing the wellness of people. Since its launch in October of 2018, the site has published articles on the medical, economic, and lifestyle potential of hemp. For people buying CBD online, Remedy Review is the only product review site that uses 3rd-party testing to protect consumers and hold brands accountable.

For more information, please visit: https://www.remedyreview.com

About Avazyme, Inc.

Avazyme, Inc. offers custom-tailored testing solutions for agriculture, pesticide and biopesticide, biotechnology and pharmaceutical industries and the entire food value chain, performed under the highest quality standards, including GLPs. The founder, President and CEO of Avazyme, Volker Bornemann, Ph.D., is also an adjunct professor at NCSU and on the AgTech Scientific Advisory Board of the North Carolina Biotechnology Center. Avazyme has acquired the state and federal permits to legally handle any controlled substances (DEA Schedule 1 through 5), including Cannabis and products derived thereof, at its laboratory facility.

For more information, please visit: https://www.avazyme.com

CONTACT:
Marc Lewis
Executive Editor
marc@remedyreview.com

More on Rezul News

• NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
• Broadway Gala Honored Also an Italian
• $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
• AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
• CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework

LEGAL:
Remedy Review does NOT provide any medical advice, diagnosis, or treatment. If you need medical advice, diagnosis, or treatment, please see a physician and do NOT use Remedy Review for that purpose. Further, Remedy Review does not and cannot recommend treatment or offer medical advice on personal health matters. The contents contained herein and on remedyreview.com, including but not limited to all product information, are for informational purposes only and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. The contents on remedyreview.com shall not be used as a substitute for professional diagnosis or treatment. Your access to or use of the remedyreview.com does not create in any way a physician-patient relationship, any sort of confidential relationship, or any other relationship that would give rise to any duties on the part of Remedy Review, its agents, or employees. Always seek the advice of a qualified healthcare professional with any questions you may have regarding any medical condition. Never disregard medical advice or delay in seeking medical advice because of something you have read on remedyreview.com. In case of an emergency, call 911 for immediate assistance. Remedy Review makes best efforts to present accurate information in its testing and works with highly credentialed ISO-certified laboratories to produce test results. Neither Remedy Review nor any party involved in creating, producing or delivering remedyreview.com shall be liable for any direct, incidental, consequential, indirect, or punitive damages arising out of user's access, use, or inability to use remedyreview.com, or any errors or omissions in the content of remedyreview.com.

SOURCE Remedy Review

Related Links

https://www.remedyreview.com

---

Show All News | Report Violation